Changes in Fluoroquinolone-Resistant Streptococcus pneumonia after 7-Valent Conjugate Vaccination, Spain

Among 4,215 Streptococcus pneumoniae isolates obtained in Spain during 2006, 98 (2.3%) were ciprofloxacin resistant (3.6% from adults and 0.14% from children). In comparison with findings from a 2002 study, global resistance remained stable. Low-level resistance (30 isolates with MIC 4–8 μg/mL) was...

Full description

Bibliographic Details
Main Authors: Adela G. de la Campa, Carmen Ardanuy, Luz Balsalobre, Emilio Pérez-Trallero, Jose M. Marimón, Asunción Fenoll, Josefina Liñares
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2009-06-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/15/6/08-0684_article
_version_ 1818261662177689600
author Adela G. de la Campa
Carmen Ardanuy
Luz Balsalobre
Emilio Pérez-Trallero
Jose M. Marimón
Asunción Fenoll
Josefina Liñares
author_facet Adela G. de la Campa
Carmen Ardanuy
Luz Balsalobre
Emilio Pérez-Trallero
Jose M. Marimón
Asunción Fenoll
Josefina Liñares
author_sort Adela G. de la Campa
collection DOAJ
description Among 4,215 Streptococcus pneumoniae isolates obtained in Spain during 2006, 98 (2.3%) were ciprofloxacin resistant (3.6% from adults and 0.14% from children). In comparison with findings from a 2002 study, global resistance remained stable. Low-level resistance (30 isolates with MIC 4–8 μg/mL) was caused by a reserpine-sensitive efflux phenotype (n = 4) or single topoisomerase IV (parC [n = 24] or parE [n = 1]) changes. One isolate did not show reserpine-sensitive efflux or mutations. High-level resistance (68 isolates with MIC ≥16 μg/mL) was caused by changes in gyrase (gyrA) and parC or parE. New changes in parC (S80P) and gyrA (S81V, E85G) were shown to be involved in resistance by genetic transformation. Although 49 genotypes were observed, clones Spain9V-ST156 and Sweden15A-ST63 accounted for 34.7% of drug-resistant isolates. In comparison with findings from the 2002 study, clones Spain14-ST17, Spain23F-ST81, and ST8819F decreased and 4 new genotypes (ST9710A, ST57016, ST43322, and ST71733) appeared in 2006.
first_indexed 2024-12-12T18:50:47Z
format Article
id doaj.art-3d08b429b9754abb808aa84f696bf4fc
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-12-12T18:50:47Z
publishDate 2009-06-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-3d08b429b9754abb808aa84f696bf4fc2022-12-22T00:15:23ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592009-06-0115690591110.3201/eid1506.080684Changes in Fluoroquinolone-Resistant Streptococcus pneumonia after 7-Valent Conjugate Vaccination, SpainAdela G. de la CampaCarmen ArdanuyLuz BalsalobreEmilio Pérez-TralleroJose M. MarimónAsunción FenollJosefina LiñaresAmong 4,215 Streptococcus pneumoniae isolates obtained in Spain during 2006, 98 (2.3%) were ciprofloxacin resistant (3.6% from adults and 0.14% from children). In comparison with findings from a 2002 study, global resistance remained stable. Low-level resistance (30 isolates with MIC 4–8 μg/mL) was caused by a reserpine-sensitive efflux phenotype (n = 4) or single topoisomerase IV (parC [n = 24] or parE [n = 1]) changes. One isolate did not show reserpine-sensitive efflux or mutations. High-level resistance (68 isolates with MIC ≥16 μg/mL) was caused by changes in gyrase (gyrA) and parC or parE. New changes in parC (S80P) and gyrA (S81V, E85G) were shown to be involved in resistance by genetic transformation. Although 49 genotypes were observed, clones Spain9V-ST156 and Sweden15A-ST63 accounted for 34.7% of drug-resistant isolates. In comparison with findings from the 2002 study, clones Spain14-ST17, Spain23F-ST81, and ST8819F decreased and 4 new genotypes (ST9710A, ST57016, ST43322, and ST71733) appeared in 2006.https://wwwnc.cdc.gov/eid/article/15/6/08-0684_articleStreptococcus pneumoniaestreptococciDNA topoisomerasesfluoroquinolonesciprofloxacinantimicrobial resistance
spellingShingle Adela G. de la Campa
Carmen Ardanuy
Luz Balsalobre
Emilio Pérez-Trallero
Jose M. Marimón
Asunción Fenoll
Josefina Liñares
Changes in Fluoroquinolone-Resistant Streptococcus pneumonia after 7-Valent Conjugate Vaccination, Spain
Emerging Infectious Diseases
Streptococcus pneumoniae
streptococci
DNA topoisomerases
fluoroquinolones
ciprofloxacin
antimicrobial resistance
title Changes in Fluoroquinolone-Resistant Streptococcus pneumonia after 7-Valent Conjugate Vaccination, Spain
title_full Changes in Fluoroquinolone-Resistant Streptococcus pneumonia after 7-Valent Conjugate Vaccination, Spain
title_fullStr Changes in Fluoroquinolone-Resistant Streptococcus pneumonia after 7-Valent Conjugate Vaccination, Spain
title_full_unstemmed Changes in Fluoroquinolone-Resistant Streptococcus pneumonia after 7-Valent Conjugate Vaccination, Spain
title_short Changes in Fluoroquinolone-Resistant Streptococcus pneumonia after 7-Valent Conjugate Vaccination, Spain
title_sort changes in fluoroquinolone resistant streptococcus pneumonia after 7 valent conjugate vaccination spain
topic Streptococcus pneumoniae
streptococci
DNA topoisomerases
fluoroquinolones
ciprofloxacin
antimicrobial resistance
url https://wwwnc.cdc.gov/eid/article/15/6/08-0684_article
work_keys_str_mv AT adelagdelacampa changesinfluoroquinoloneresistantstreptococcuspneumoniaafter7valentconjugatevaccinationspain
AT carmenardanuy changesinfluoroquinoloneresistantstreptococcuspneumoniaafter7valentconjugatevaccinationspain
AT luzbalsalobre changesinfluoroquinoloneresistantstreptococcuspneumoniaafter7valentconjugatevaccinationspain
AT emiliopereztrallero changesinfluoroquinoloneresistantstreptococcuspneumoniaafter7valentconjugatevaccinationspain
AT josemmarimon changesinfluoroquinoloneresistantstreptococcuspneumoniaafter7valentconjugatevaccinationspain
AT asuncionfenoll changesinfluoroquinoloneresistantstreptococcuspneumoniaafter7valentconjugatevaccinationspain
AT josefinalinares changesinfluoroquinoloneresistantstreptococcuspneumoniaafter7valentconjugatevaccinationspain